Genetics of high-dose methotrexate-induced oral mucositis: current perspectives

Pharmacogenomics. 2019 Jun;20(9):621-623. doi: 10.2217/pgs-2019-0062.
No abstract available

Keywords: methotrexate; mucositis; pharmacogenetics; toxicity.

Publication types

  • Editorial

MeSH terms

  • Antimetabolites, Antineoplastic / administration & dosage
  • Antimetabolites, Antineoplastic / adverse effects*
  • Antimetabolites, Antineoplastic / therapeutic use
  • DNA Methylation / genetics
  • Dose-Response Relationship, Drug
  • Humans
  • Methotrexate / administration & dosage
  • Methotrexate / adverse effects*
  • Methotrexate / therapeutic use
  • Methylenetetrahydrofolate Reductase (NADPH2) / genetics
  • Pharmacogenomic Variants / genetics*
  • Stomatitis / chemically induced*
  • Stomatitis / genetics*
  • Thymidylate Synthase / genetics

Substances

  • Antimetabolites, Antineoplastic
  • MTHFR protein, human
  • Methylenetetrahydrofolate Reductase (NADPH2)
  • TYMS protein, human
  • Thymidylate Synthase
  • Methotrexate